European Parliament signs off on remaining piece of Horizon 2020 worth €9B
Next generation of public-public research programmes in fields of clinical trials, SME financing, active ageing and metrology among initiatives that received green light from MEPs
Raiding the underwater medicine cabinet: the EU’s €9.5M venture into the sea
As resistance to traditional antibiotics reaches crisis levels, scientists are poised to forage in hard-to-reach sea trenches for new antimicrobials and novel compounds that could provide the basis of new drugs
  • Viewpoints
  • EU Highlights
  • Science|Business Network
  • Innovation Board
“We expected to receive around 150 applications a year and fund around 40 projects. But we ended up with 600-700 applications and 150 projects annually”
With the Eurostars’ funding pot replenished by nearly €1.2B, EUREKA chairwoman Kristin Danielsen shares her thoughts on its importance for small businesses in Europe
Europe needs maritime spatial planning to avoid over-exploitation of our seas
Growth in the marine sector is welcome, but needs to be sensitively managed; we shouldn’t put wind turbines in fishing grounds. Investing in seabed mapping technology will ensure resources are used in a sustainable way, says Maria do Céu Patrão Neves, MEP
Science and entrepreneurship can beat climate change
In response to the latest IPCC report, Mary Ritter, CEO of Climate-KIC, the EU’s public-private partnership, highlights the major efforts that are under way to tackle climate change. Collaboration is the route to addressing this threat, she says
European Parliament signs off on remaining piece of Horizon 2020 worth €9B
Next generation of public-public research programmes in fields of clinical trials, SME financing, active ageing and metrology among initiatives that received green light from MEPs
Fall in demand for European Research Council grants in first Horizon 2020 call
A decrease in applications of almost two per cent is attributed to the ineligibility of Swiss scientists and new rules on re-submission
EC energy policy shift for 2030: a competitive low-carbon economy
Subsidies for renewable energies should be progressively eliminated where they distort competition, Director-General Dominique Ristori tells Science|Business

Karolinska led team of researchers identifies a new general concept for the treatment of cancer
A team of researchers from five Swedish universities, led by Karolinska Institutet and the Science for Life Laboratory, have identified a new way of treating cancer. The concept is presented in the journal Nature and is based on inhibiting a specific enzyme called MTH1, which cancer cells, unlike normal cells, require for survival. Without this enzyme, oxidized nucleotides are incorporated into DNA, resulting in lethal DNA double-strand breaks in cancer cells.
Bioprinting new organs at Chalmers
With the new 3D Bioprinter, the research group of Professor Paul Gatenholm at the Department of Chemical and Biological Engineering exploits new possibilities of tissue engineering and organ regeneration.
Students in ESADE's Master in Innovation and Entrepreneurship, winners of Startup Weekend Barcelona
Sebastian Bausch and Bernard Jansen of ESADE win the Google-organised event with "Yuki wearables for kids"

Helping Europe Innovate
Science|Business Innovation Board AISBL Annual Report 2012-2013
A Grace Period for Patents
Could it help European universities innovate?
Inside the mind of European academic entrepreneurs
Perceptions of ACES finalists about the process of science entrepreneurship

Gas: Too much of a good thing?
Over the past five years, the US shale gas boom has brought about dramatic changes in the North American energy landscape, prompting economic and environmental debate in Europe and other parts of the world.
Europe's champion innovators
The Science|Business Academic Enterprise Awards have thrown a spotlight on 70 of Europe’s hottest technology spin-outs. The ACES winners are individuals who created companies based on cutting-edge research.
Experts debate the future of stem cells
Europe is currently a world leader in the fundamental science underpinning regenerative medicine and cell therapy, and in its therapeutic use and regulation. But how can Europe build on its leading position?
>More Innovation Intelligence
Horizon 2020 Special Coverage
Pharma Day (Partner Event)
A high-level meeting, on the means for facilitating the transition from scientific discovery to clinical applications in oncology.
Warszaw, Poland - 25 April 2014
Research Commercialisation: From Ideas to IPO (Partner Event)
Research Commercialisation is a new cross-discipline event and will provide a platform for all those involved in promoting university-industry-investor collaboration, technology transfer and start-ups.
London, UK - 19 May 2014
ACES Selection Committee
The Academic Enterprise Awards (ACES) Selection Committee meets to short list the finalists of the 2014 awards.
Copenhagen - 23 June 2014
So you want to start a company?
A workshop on forming a university spin-out company. Jointly organised by Science|Business and ASTP Proton as part of the ESOF conference.
Copenhagen - 25 June 2014
Webinar: Smarter Data for a Healthier Society
Experts discuss how public sector information can play an increasingly important role in helping Europe reap the economic and social benefits of 'Big Data'.
Webinar: How Europe can build on its leading position in regenerative medicine
Following a positive ruling on patents and a decision to maintain funding for embryonic stem cell research in Horizon 2020, experts say that things are looking up for regenerative medicine.
Webcast: Can EU = Entrepreneurship Union?
How can the EU help to get more technology start-ups moving? Join us to hear about the EU's new €2.5 billion support programme for small companies, government procurement and university incubators.